Analysis of tumor protein p53 (p53) mutations in eyelid malignancy

---

Original Article

Author Details : Rajendra Prakash Maurya*, Sanjay Kumar Bosak, Royana Singh, Virendra Pratap Singh, Samer Singh, Per O Lundmark, Shivangi Singh, Anil Kumar, Tanmay Srivastav

Volume : 7, Issue : 3, Year : 2021

Article Page : 243-249

https://doi.org/10.18231/j.ijooo.2021.051

Suggest article by email

Get Permission

---

Abstract

Purpose: The tumor protein p53 (or p53) gene plays a major role in the maintenance of normal cell growth and differentiation. Alteration in p53 gene is responsible for carcinogenesis. In this study, we evaluated the frequency of p53 mutation and clinicopathological findings in various eyelid malignancies.
Materials and Methods: We reviewed a cohort of 20 patients with various eyelid malignancies over one year. The expression of p53protein was analyzed by amplifying the exons 5-9 of p53 gene by conventional Polymerase Chain Reaction (PCR) followed by sequencing to identify mutations.
Results: The commonest eyelid malignancies was sebaceous gland carcinoma (SGC;50%) followed by basal cell carcinoma (BCC;45%) and squamous cell carcinoma(SCC; 5%). Study population/patients were mostly elderly (60 %, > 50 years of age) and female (75%). A total of 14 mutations were identified in the p53 genes in 9/20 (45%) patients at different intron or exon. Amongst them 6 patients (66.7%) had SGC and 3 (33.3%) had BCC. Out of the total 14 mutations identified, 8 intronic variation and 6 exonic mutations were identified. Out of 6 exonic variations, 5 caused frame shift mutations due to insertion or deletion of bases and one case was of substitution mutation (D281Y).
Conclusion: Sebaceous gland carcinoma (SGC) was found to be most prevalent eyelid cancer in the present study and it most frequent displayed mutation inthe p53 genes among the all eyelid tumors investigated.
 
Keywords: p53protein, PCR, Eyelid tumor, Mutation, Polymorphism, Sequencing, Sebaceous gland carcinoma, Basal cell carcinoma, Squamous cell carcinoma

How to cite : Maurya R P, Bosak S K, Singh R, Singh V P, Singh S, Lundmark P O, Singh S, Kumar A, Srivastav T, Analysis of tumor protein p53 (p53) mutations in eyelid malignancy. IP Int J Ocul Oncol Oculoplasty 2021;7(3):243-249

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.